1. Home
  2. BGMS vs CDIO Comparison

BGMS vs CDIO Comparison

Compare BGMS & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio Green Med Solution Inc.

BGMS

Bio Green Med Solution Inc.

HOLD

Current Price

$1.06

Market Cap

5.9M

Sector

N/A

ML Signal

HOLD

Logo Cardio Diagnostics Holdings Inc.

CDIO

Cardio Diagnostics Holdings Inc.

HOLD

Current Price

$1.99

Market Cap

5.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGMS
CDIO
Founded
1996
2017
Country
Malaysia
United States
Employees
19
17
Industry
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
5.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BGMS
CDIO
Price
$1.06
$1.99
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.3M
39.9K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$171,906.75
Revenue Next Year
$80,482.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$0.97
52 Week High
$6.70
$7.91

Technical Indicators

Market Signals
Indicator
BGMS
CDIO
Relative Strength Index (RSI) 58.45 49.73
Support Level $0.89 $1.68
Resistance Level $1.12 $2.13
Average True Range (ATR) 0.12 0.17
MACD 0.04 0.00
Stochastic Oscillator 79.15 22.22

Price Performance

Historical Comparison
BGMS
CDIO

About BGMS Bio Green Med Solution Inc.

Bio Green Med Solution Inc is engaged in the supply and trading of protective and fire safety equipment. The company distributes products such as fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and safety apparel. It also provides fire safety systems, including sprinkler systems, fire alarm systems, valves, and CO2 systems. The company operates across commercial, industrial, healthcare, and residential sectors, with a focus on distribution and compliance with applicable safety standards.

About CDIO Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

Share on Social Networks: